Back to Posts

Back to Posts

August 10, 2022 Regulatory Sciences

EMA COVID-19 guidance: research and development


The European Medicines Agency (EMA) provides support to medicine developers researching and developing potential COVID-19 medicines. Dedicated guidance, rapid procedures and contact points are available.

EMA: COVID-19 guidance: research and development

Table of contents

Interested in learning more? Contact us today to find out how we can help with your global regulatory needs.

 



Your Business has Complex Challenges. ProPharma Group has Exceptional Solutions.

We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.

Interested in gaining an industry edge? Let us help you stay up to date.


All fields are required.
There was a problem with your submission. Errors have been highlighted below.